Insignia Financial Ltd (AU:IFL) has released an update.
Insignia Financial Ltd has announced that it has become a substantial shareholder in Argenica Therapeutics Limited, with a total voting power of 5.072%. The acquisition includes 6,274,450 ordinary shares, with MLC Investments Ltd and IOOF Investment Services Ltd registered as holders of these securities. The shares were bought on the market over a series of transactions in the months leading up to July 4, 2024.
For further insights into AU:IFL stock, check out TipRanks’ Stock Analysis page.
